MIC Financial
  • Home
  • Medicare
  • Medicare Options
  • Team
  • Testimonials
  • News
  • More Information
  • Home
  • Medicare
  • Medicare Options
  • Team
  • Testimonials
  • News
  • More Information

Blog

Huge Metformin Recall Due To Cancer Causing Contaminant

By Tom Matteson - In Uncategorized - October 12, 2020

Diabetes Drug Recalled Due To High Levels Of Cancer-Causing Contaminant

October 11, 2020 at 9:44 am

NEW YORK (CBSNewYork/CNN) — A widely-used diabetes drug is being recalled after manufacturers found it contained unacceptably high levels of a cancer-causing contaminant.

Indian pharmaceutical company Marksans Pharma Limited is recalling metformin hydrochloride extended-release tablets because their levels of NDMA, a “probable human carcinogen,” were higher than the acceptable daily intake limit of 96 nanograms per day, according to a recall published this week by the US Food and Drug Administration (FDA).

Metformin tablets are used to treat type 2 diabetes and are designed to lower glucose levels.

The recall applies to metformin tablets between 500 mg and 750 mg, sold under the brand name Time-Cap Labs, Inc.

RELATED STORY: Study Shows Adolescents, Young Adults At Increasing Risk For Prediabetes

The recall expands an earlier recall of the same product from this summer. But it’s just one of several metformin products that have been found to contain NDMA in the last year. Seven other pharmaceutical companies have issued recalls for metformin hydrochloride extended-release tablets due to their carcinogenic contents.

The FDA is still investigating where NDMA comes from and how it ends up in metformin products. Most levels found in medications are generally low and fall within the FDA’s accepted daily intake, but recently recalled medications exceed that. Marksans Pharma Limited, India, however, did not reveal how much NDMA its recalled products contained.

The recall applies to the following products, which can be identified by their National Drug Code numbers listed below (National Drug Codes can be used to search and identify products online through the FDA). The tablets are either embossed with 101 or 102 on one side and are plain on the other.

Metformin Hydrochloride Extended-Release Tablets, USP 500mg:

90 counts: 49483-623-09

100 counts: 49483-623-01

500 counts: 49483-623-50

1000 counts: 49483-623-10

Metformin Hydrochloride Extended-Release Tablets, USP 750mg:

100 counts: 49483-624-01

You can get the latest news, sports and weather on our brand new CBS New York app. Download here.

(© Copyright 2020 CBS Broadcasting Inc. All Rights Reserved. Cable News Network, Inc., a WarnerMedia Company, contributed to this report.)

About Author

Tom Matteson

← Med Sup Cost Comparison
The Truth About Medicare Advantage Plans And All Those Commercials We See All Day Long →

Recent Posts

  • Medicare Math” Changes to 2025 Medicare calculations for prescription drugs
  • New book sheds light on how Medicare advantage plans really work.
  • Older Americans say they feel trapped in Medicare Advantage plans
  • Try Medicare Disadvantage
  • Medicare Costs Increase For 2022

Archives

  • September 2024
  • February 2024
  • January 2024
  • December 2022
  • February 2022
  • November 2021
  • October 2020
  • August 2020
  • June 2020
  • January 2020
  • November 2019
  • October 2019
  • September 2019
  • May 2019
  • April 2019
  • February 2019
  • January 2019
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018

Categories

  • blog
  • Uncategorized

We are not connected with or endorsed by the United States Government or the Federal Medicare Program.

MIC Financial
© 2020 All Rights Reserved

Quick Links

  • Medicare
  • Medicare Options
  • Agents
  • News
  • More Information
  • Testimonials
  • BBB Accreditation
  • Privacy Notice

Office Address
7815 N Dale Mabry Hwy
Suite # 108
Tampa, Florida 33614
Phone: 855-830-6099
Fax: 813-901-8975
E-mail: info@micfinancial.net

Medicare Insurance Consultants, LLC, Insurance  Medicare Supplement, Tampa, FL